Morgan Stanley Green Light Biosciences Holdings, Pbc Transaction History

Morgan Stanley

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.18 - $0.48 $1,752 - $4,674	-9,738 Reduced 12.44%	68,557 $20,000
Q1 2023 May 15, 2023	BUY	$0.34 - $1.19 $5,517 - $19,311	16,228 Added 26.15%	78,295 $33,000
Q4 2022 Feb 14, 2023	BUY	$1.03 - $2.0 $13,417 - $26,054	13,027 Added 26.56%	62,067 $73,000
Q3 2022 Nov 14, 2022	BUY	$0.42 - $3.92 $13,489 - $125,902	32,118 Added 189.8%	49,040 $113,000
Q2 2022 Oct 27, 2022	BUY	N/A	11,222 Added 196.88%	16,922 $38,000
Q2 2022 Aug 15, 2022	BUY	N/A	11,222 Added 196.88%	16,922 $38,000
Q1 2022 Oct 27, 2022	SELL	N/A	-11,222 Reduced 66.32%	5,700 $55,000
Q1 2022 May 13, 2022	BUY	N/A	5,700 New	5,700 $55,000

51.5K

Ticker GRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 151,460,000
Description
GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid (RNA) products for human health and agriculture applications. Its products for human health include mRNA vaccines and therapeutics; and agricultural RNA products to protect honeybees and crops. The company was founded in 2008 and is headquartered in...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.